Morbus Fabry gehört zu einer Gruppe von Erkrankungen, die als lysosomale Speicherkrankheiten bekannt sind. Es handelt sich um eine seltene genetische Erkrankung, die viele Teile des Körpers betreffen kann, darunter Nieren, Herz und Haut. Der Patient leidet unter einem Mangel des Enzyms Alpha-Galactosidase, was zu einer fortschreitenden Organfunktionsstörung führt. Die abnormale Ansammlung einer bestimmten Fettsubstanz wird Globotriaosylceramid genannt und ist hauptsächlich für die Entstehung von Fabry-Erkrankungen verantwortlich.
MARKDTYNAMIK
Es wird erwartet, dass der Markt für die Behandlung von Fabry-Erkrankungen aufgrund der Unterstützung staatlicher Stellen für die Behandlung von Fabry-Erkrankungen wächst Lebensmittel- und Arzneimittelbehörde (FDA). Allerdings bremsen mangelndes Bewusstsein über Fortschritte in den Genwissenschaften und technologische Einschränkungen in einer bestimmten Region der Welt das Marktwachstum. Darüber hinaus treiben umfangreiche Forschungs- und Entwicklungsaktivitäten den Markt für die Behandlung von Fabry-Erkrankungen im Prognosezeitraum voran.
MARKTUMFANG
Der „Markt für die Behandlung von Fabry-Erkrankungen“. „Analyse bis 2031“ ist eine spezialisierte und tiefgreifende Studie der Pharmaindustrie mit besonderem Fokus auf die globale Markttrendanalyse. Ziel des Berichts ist es, einen Überblick über den Markt für die Behandlung von Fabry-Erkrankungen mit einer detaillierten Marktsegmentierung nach Medikamententyp und Geografie zu geben. Es wird erwartet, dass der Markt für die Behandlung von Fabry-Erkrankungen im Prognosezeitraum ein hohes Wachstum verzeichnen wird. Der Bericht liefert wichtige Statistiken zum Marktstatus der führenden Marktteilnehmer im Bereich der Fabry-Disease-Behandlung und bietet wichtige Trends und Chancen auf dem Markt.
MARKTSEGMENTIERUNG
< br />Der Markt für die Behandlung der Fabry-Krankheit ist nach Medikamententyp segmentiert. Basierend auf der Medikamentenart wird der Markt in Enzymersatztherapie (ERT), Chaperonbehandlung, Substratreduktionstherapie (SRT) und andere unterteilt.
< br />Der Bericht bietet einen detaillierten Überblick über die Branche, einschließlich qualitativer und quantitativer Informationen. Es bietet einen Überblick und eine Prognose des Marktes für die Behandlung von In-Fabry-Erkrankungen basierend auf verschiedenen Segmenten. Es bietet auch Marktgrößen- und Prognoseschätzungen für die Jahre 2021 bis 2031 in Bezug auf fünf Hauptregionen, nämlich: Nordamerika, Europa, Asien-Pazifik (APAC), Naher Osten und Afrika (MEA) sowie Süd- und Afrika. Zentralamerika. Der Markt für die Behandlung von Morbus Fabry nach Regionen wird später nach Ländern und Segmenten unterteilt. Der Bericht umfasst Analysen und Prognosen für 18 Länder weltweit sowie aktuelle Trends und Chancen in der Region.
Der Bericht analysiert Faktoren, die den Markt für die Behandlung von Morbus Fabry sowohl auf der Nachfrage- als auch auf der Angebotsseite beeinflussen, und bewertet weiter die beeinflussende Marktdynamik den Markt während des Prognosezeitraums, d. h. Treiber, Beschränkungen, Chancen und zukünftige Trends. Der Bericht bietet außerdem eine umfassende Schädlingsanalyse für alle fünf Regionen, nämlich: Nordamerika, Europa, APAC, MEA und Süd- und Südamerika Mittelamerika nach Bewertung politischer, wirtschaftlicher, sozialer und technologischer Faktoren, die den Markt für die Behandlung von Fabry-Erkrankungen in diesen Regionen beeinflussen.
MARKTSPIELER
Der Bericht behandelt wichtige Entwicklungen auf dem Markt für die Behandlung von In-Fabry-Erkrankungen als organische und anorganische Wachstumsstrategien. Verschiedene Unternehmen konzentrieren sich auf organische Wachstumsstrategien wie Produkteinführungen, Produktzulassungen und andere wie Patente und Veranstaltungen. Zu den auf dem Markt beobachteten anorganischen Wachstumsstrategien gehörten Akquisitionen sowie Partnerschaften und Partnerschaften. Kooperationen. Diese Aktivitäten haben den Weg für die Erweiterung des Geschäfts und des Kundenstamms der Marktteilnehmer geebnet. Es wird erwartet, dass die Marktteilnehmer auf dem Markt für die Behandlung von Fabry-Erkrankungen in Zukunft lukrative Wachstumschancen haben werden, da die Nachfrage nach dem Markt für die Behandlung von Fabry-Erkrankungen auf dem Weltmarkt steigt. Nachfolgend finden Sie eine Liste einiger Unternehmen, die auf dem Markt für die Behandlung von Fabry-Erkrankungen tätig sind.
Der Bericht enthält auch die Profile der wichtigsten Unternehmen auf dem Markt für die Behandlung von Fabry-Erkrankungen sowie deren SWOT-Analyse und Marktstrategien. Darüber hinaus konzentriert sich der Bericht auf führende Branchenakteure mit Informationen wie Unternehmensprofilen, angebotenen Komponenten und Dienstleistungen, Finanzinformationen der letzten drei Jahre und wichtigen Entwicklungen in den letzten fünf Jahren.
- • Amicus Therapeutics Inc. • Avrobio Inc. • Greenovation Biotech GmbH • Idorsia Pharmaceuticals Ltd. • ISU Abxis Co Ltd. • JCR Pharmaceuticals Co Ltd • Moderna Therapeutics Inc. • Protalix Biotherapeutics Inc.• Sanofi SA• Shire Plc.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Fabry Disease Treatment Market is expected to grow at a CAGR of 6.8% between 2023-2031
Much of the treatment market for Fabry disease is propelled by several factors, including an ever-increasing incidence of the disease, new diagnostic techniques, and innovations in therapies. The enlarged demographic of senior citizens, coupled with awareness and earlier diagnosis, is fueling the growth of the market. Furthermore, both favorable reimbursement policies and increasing healthcare expenditure are working in favor of expensive treatments. In addition, a robust pipeline of therapeutic candidates under development is expected to propel the future growth of the market.
Major changes are expected in the treatment market of Fabry disease in the years to come. Prominent factors influencing the treatment market are continued development of novel therapies, including gene therapy and small molecule inhibitors, which may offer more targeted and effective treatments. Advances in diagnostic techniques, particularly newborn screening, will mean earlier diagnosis and intervention. Additionally, the increasing focus on personalized medicine will drive the development of tailored treatment strategies based on individual patient characteristics. As the understanding of Fabry disease progresses and new therapies emerge, the market is poised for significant growth and transformation.
The leading players of the market are: Amicus Therapeutics Inc., Avrobio Inc., Greenovation Biotech GmbH, Idorsia Pharmaceuticals Ltd., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd, Moderna Therapeutics Inc., Protalix Biotherapeutics Inc., Sanofi S.A., Shire Plc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Amicus Therapeutics Inc.
2. Avrobio Inc.
3. Greenovation Biotech GmbH
4. Idorsia Pharmaceuticals Ltd.
5. ISU Abxis Co Ltd.
6. JCR Pharmaceuticals Co Ltd
7. Moderna Therapeutics Inc.
8. Protalix Biotherapeutics Inc.
9. Sanofi S.A.
10. Shire Plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For